Literature DB >> 10531249

A DNA sequence corresponding to the gene encoding cysteine proteinase 5 in Entamoeba histolytica is present and positionally conserved but highly degenerated in Entamoeba dispar.

U Willhoeft1, L Hamann, E Tannich.   

Abstract

Cysteine proteinases of Entamoeba histolytica are considered to be one of the most important classes of molecules responsible for the parasite's ability to destroy human tissues. Interestingly, one particular cysteine proteinase, located on the surface of E. histolytica trophozoites and designated cysteine proteinase 5 (CP5), is not expressed in the closely related but nonpathogenic species Entamoeba dispar. By comparing the E. histolytica and E. dispar genomic loci containing the gene for CP5 (cp5), it was found that the position of cp5 within the genomic context is conserved between the two organisms, but that the gene is highly degenerated in E. dispar, as it contains numerous nucleotide exchanges, insertions, and deletions, resulting in multiple stop codons within the cp5 reading frame. An alignment of all available orthologous E. histolytica and E. dispar DNA sequences suggested that cp5 started to degenerate in E. dispar coincidently when the two organisms began to diverge from a common ancestor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531249      PMCID: PMC96975     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Amoebapores.

Authors:  M Leippe
Journal:  Parasitol Today       Date:  1997-05

2.  Entamoeba histolytica and Entamoeba dispar: differences in numbers and expression of cysteine proteinase genes.

Authors:  I Bruchhaus; T Jacobs; M Leippe; E Tannich
Journal:  Mol Microbiol       Date:  1996-10       Impact factor: 3.501

Review 3.  Archaea and the prokaryote-to-eukaryote transition.

Authors:  J R Brown; W F Doolittle
Journal:  Microbiol Mol Biol Rev       Date:  1997-12       Impact factor: 11.056

4.  A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba.

Authors:  L S Diamond; D R Harlow; C C Cunnick
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

5.  Putative serine/threonine protein kinase expressed in complement-resistant forms of Entamoeba histolytica.

Authors:  B Urban; C Blasig; B Förster; C Hamelmann; R D Horstmann
Journal:  Mol Biochem Parasitol       Date:  1996-10-01       Impact factor: 1.759

6.  Cysteine endopeptidases of Entamoeba histolytica.

Authors:  H Scholze; E Tannich
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

7.  A new liquid medium for xenic cultivation of Entamoeba histolytica and other lumen-dwelling protozoa.

Authors:  L S Diamond
Journal:  J Parasitol       Date:  1982-10       Impact factor: 1.276

8.  Differentiation of pathogenic from nonpathogenic Entamoeba histolytica by restriction fragment analysis of a single gene amplified in vitro.

Authors:  E Tannich; G D Burchard
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

Review 9.  Recent progress in the molecular biology of Entamoeba histolytica.

Authors:  R D Horstmann; M Leippe; E Tannich
Journal:  Trop Med Parasitol       Date:  1992-12

Review 10.  A redescription of Entamoeba histolytica Schaudinn, 1903 (Emended Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925.

Authors:  L S Diamond; C G Clark
Journal:  J Eukaryot Microbiol       Date:  1993 May-Jun       Impact factor: 3.346

View more
  22 in total

1.  A retromerlike complex is a novel Rab7 effector that is involved in the transport of the virulence factor cysteine protease in the enteric protozoan parasite Entamoeba histolytica.

Authors:  Kumiko Nakada-Tsukui; Yumiko Saito-Nakano; Vahab Ali; Tomoyoshi Nozaki
Journal:  Mol Biol Cell       Date:  2005-08-24       Impact factor: 4.138

2.  Intestinal invasion by Entamoeba histolytica.

Authors:  Shahram Solaymani-Mohammadi; William A Petri
Journal:  Subcell Biochem       Date:  2008

3.  The E. histolytica Genome Structure and Virulence.

Authors:  Carol A Gilchrist
Journal:  Curr Trop Med Rep       Date:  2016-10-03

4.  The abundant polyadenylated transcript 2 DNA sequence of the pathogenic protozoan parasite Entamoeba histolytica represents a nonautonomous non-long-terminal-repeat retrotransposon-like element which is absent in the closely related nonpathogenic species Entamoeba dispar.

Authors:  Ute Willhoeft; Heidrun Buss; Egbert Tannich
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 5.  Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel.

Authors:  Damien Stark; Joel Barratt; Douglas Chan; John T Ellis
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

6.  Comparative genomic hybridizations of Entamoeba strains reveal unique genetic fingerprints that correlate with virulence.

Authors:  Preetam H Shah; Ryan C MacFarlane; Dhruva Bhattacharya; John C Matese; Janos Demeter; Suzanne E Stroup; Upinder Singh
Journal:  Eukaryot Cell       Date:  2005-03

7.  Identification of an Entamoeba histolytica serine-, threonine-, and isoleucine-rich protein with roles in adhesion and cytotoxicity.

Authors:  Ryan C MacFarlane; Upinder Singh
Journal:  Eukaryot Cell       Date:  2007-09-07

8.  Entamoeba histolytica cysteine proteinases disrupt the polymeric structure of colonic mucin and alter its protective function.

Authors:  Darcy Moncada; Kathy Keller; Kris Chadee
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

9.  Giardia, Entamoeba, and Trichomonas enzymes activate metronidazole (nitroreductases) and inactivate metronidazole (nitroimidazole reductases).

Authors:  Dibyarupa Pal; Sulagna Banerjee; Jike Cui; Aaron Schwartz; Sudip K Ghosh; John Samuelson
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

10.  An ex-vivo human intestinal model to study Entamoeba histolytica pathogenesis.

Authors:  Devendra Bansal; Patrick Ave; Sophie Kerneis; Pascal Frileux; Olivier Boché; Anne Catherine Baglin; Geneviève Dubost; Anne-Sophie Leguern; Marie-Christine Prevost; Rivka Bracha; David Mirelman; Nancy Guillén; Elisabeth Labruyère
Journal:  PLoS Negl Trop Dis       Date:  2009-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.